Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Mitochondrial problems in diabetic nerve damage might cause pain by lowering the production of certain nerve-related steroids.

Researchers developed a nanomedicine for acne treatment that delivers medication with less irritation and is non-irritating for oily skin.

Combining platelet-rich plasma therapy with low dose oral minoxidil improved hair growth in men with hair loss, with slightly higher satisfaction at the higher minoxidil dose.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Direct-to-consumer teledermatology effectively treats male hair loss but may increase drug costs and requires monitoring for side effects.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Minoxidil nanoparticles improve hair growth more effectively than regular minoxidil.

Gamma-ray exposure improves genome editing efficiency in mice using the i-GONAD method.

A new method using hydrogels and microneedle patches improves minoxidil delivery for better hair growth.

Using a strong allergy medicine too often on the scalp can cause swelling and inflammation.

The Greek DCQ is a reliable and valid tool for assessing dysmorphic concern.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

The herbal extracts effectively promoted hair growth.

Allergic reactions to minoxidil may be due to the propylene glycol it is mixed with, not the minoxidil itself.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Monocyte-derived dendritic cells play a key role in UVB-induced skin sensitivity and inflammation.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

Low-dose oral minoxidil is safe for alopecia patients, even those prone to edema.

The TLMG hydrogel improves wound healing and monitoring with strong adhesion and conductivity.

ENERGI-F701 solution was found to be more effective and safer than Regaine® 2% minoxidil solution in treating female pattern hair loss, with increased hair density and less side effects.

A new treatment for hair loss shows promise with fewer side effects.

Nanostructured lipid carriers improve minoxidil delivery for hair loss treatment.

Laser and minoxidil combo promotes better hair growth than minoxidil alone, safely.

MXD@CP could be a promising new topical treatment for hair loss.

A new microneedle patch effectively treats atopic dermatitis by reducing skin stress and restoring immune balance.

Methylene blue can effectively treat severe low blood pressure from minoxidil overdose when standard treatments fail.

Dermatologist visits offer safer and more ethical treatment for hair loss than direct-to-consumer platforms.

Low-dose naltrexone helps improve symptoms and stabilize frontal fibrosing alopecia and lichen planopilaris.